Document Detail


Improved cardiac survival, freedom from mace and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions.
MedLine Citation:
PMID:  21722979     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Most percutaneous recanalizations of coronary artery chronic total occlusion (CTO) are not attempted because of the skepticism on their long-term clinical benefit. We assessed the effect of percutaneous CTO recanalization procedures on long-term cardiac survival, freedom from MACE and angina-related quality of life (AQL). METHODS: All consecutive patients who underwent attempt of percutaneous native coronary artery CTO recanalization between 2003 and 2009 were included in the study. MACE was defined as combined cardiac death, myocardial infarction (MI) and target vessel revascularization (TVR). AQL was assessed by the Seattle Angina Questionnaire-UK-version (SAQ-UK). RESULTS: Among 302 patients who received an attempt of percutaneous CTO recanalization, 237 (78%) had a successful procedure while in 65 (22%) the procedure failed. Overall intra-hospital complication rate was 3.0%, with no difference between the two groups. Median follow-up was 4.0years, during which 13 patients had a fatal cardiac event. Patients in whom the CTO recanalization procedure failed had a higher risk of cardiac death (HR 3.39; 95% CI 1.14-10.1;p=0.03; after propensity score adjustment, HR 2.83; 95% CI 0.89-8.96;p=0.07) and MACE (HR 5.40; 95% CI 2.71-10.5;p<0.001; adjusted HR 3.34; 95% CI 1.47-7.58;p=0.003) compared to patients with successful procedure. CTO recanalization significantly improved the AQL during follow-up: patients with successful procedure experienced less physical activity limitation (p=0.01), rarer angina episodes (p<0.001) and greater treatment satisfaction (p=0.03) compared to patients with failed procedure. CONCLUSIONS: Patients with successful CTO recanalization had a trend towards better cardiac survival and significant lower risk of MACE and improvement of AQL compared to patients with failed procedures.
Authors:
Francesco Borgia; Nicola Viceconte; Omar Ali; Claire Stuart-Buttle; Anjana Saraswathyamma; Rosario Parisi; Francesca Mirabella; Konstantinos Dimopoulos; Carlo Di Mario
Related Documents :
22864119 - Myocardial infarction and normal coronary arteries: the experience of the cardiology de...
21295489 - Systematic evaluation of the flexible and rigid annuloplasty ring after mitral valve re...
20532439 - Comparison of ivabradine plus beta-blockers versus beta -blocker therapy only.
1378149 - Use of multiple-action agents on the heart: pathophysiological and therapeutic consider...
18287209 - Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenor...
9731689 - Left ventricular dilatation after myocardial infarction: ace inhibitors, beta-blockers,...
24440329 - Usefulness of right ventricular dysfunction to predict new-onset atrial fibrillation fo...
2069689 - Cardiac smokers: beliefs and values about smoking, and attitudes toward the risk of smo...
21411159 - Myocardial hypertrophy after pulmonary regurgitation and valve implantation in pigs.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-30
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-7-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Establishing novel prostacyclin-synthesizing cells with therapeutic potential against heart diseases...
Next Document:  Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced techno...